Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials

Keyphrases

• Hybrid Materials 100%
• Target Molecule 100%
• Nanoconjugates 100%
• Tumor Targeting 100%
• Depot 100%
• Prolonged Release 100%
• C-X-C Chemokine Receptor Type 4 (CXCR4) 66%
• Hydrophobic Drugs 66%
• Slow-releasing 66%
• In Cancer 33%
• Tumor 33%
• Tumoral Cells 33%
• Cancer Therapy 33%
• Antitumoral Drug 33%
• Transversal 33%
• Clinical Setting 33%
• Mouse Model 33%
• Unmet Needs 33%
• Microparticles 33%
• Protein Targeting 33%
• Neoplasia 33%
• Bacterial Inclusion Bodies 33%
• Sustained Release 33%
• Secretory Granules 33%
• Therapeutic Agents 33%
• Lymphoma 33%
• Controlled Aggregation 33%
• Cytotoxic Drugs 33%
• Cell Surface Markers 33%
• Targeted Drugs 33%
• Small Tumor 33%
• Antitumoral Effect 33%
• Mechanically Stable 33%
• Subcutaneous Administration 33%
• Administration Regimen 33%
• Cytokine Receptor 33%
• Drug Conjugates 33%
• Monomethyl Auristatin E 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Nanoconjugate 100%
• Sustained Release 25%
• Mouse Model 25%
• Microparticle 25%
• Malignant Neoplasm 25%
• Cytotoxic Agent 25%
• Subcutaneous Injection 25%
• Cell Surface Marker 25%
• Vedotin 25%
• Cytokine Receptor 25%